GALWAY, Ireland, 15 April 2026 - Boston Scientific Corporation (NYSE: BSX) – a global leader in medical device technology – today announced a €75 million investment in its Galway site,...
Data highlights the WATCHMAN FLX device provided statistically superior protection from bleeding, demonstrated similar efficacy compared to blood thinners in patients with non-valvular atrial...
Global randomized trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs....
Boston Scientific has inaugurated the Institute for Advancing Science (IAS) in Milan, a new center of excellence equipped with immersive technologies like virtual reality, anatomical models, and simulators, to train healthcare professionals in advanced minimally invasive procedures.
Vincent Sourdaine discusses how precision therapy is transforming Parkinson’s disease and chronic pain treatment and explains how innovations in deep brain stimulation (DBS) and spinal cord stimulation (SCS) enable more personalized, image-guided care for better patient outcomes.
Frédéric Sacher and Laure Champ-Rigot, together with Xavier Bertrand, discuss advances in atrial fibrillation management and stroke prevention. They emphasize the importance of early diagnosis, lifestyle interventions, and innovative ablation techniques such as electroporation to safely restore heart rhythm and reduce the risk of stroke.
The BR24 feature tells the story of a patient who regained her quality of life after receiving a device that allows her to control pain at the touch of a button. The therapy uses advanced spinal cord stimulation technology to block pain signals and restore daily function.